Cambrex at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Cambrex brings 1 presentation to AAPS 2026 PharmSci 360 in New Orleans, and exhibits at Booth 918. Its program covers how to manage nitrosamine risk in a way that fits each phase of drug development.

OrganizationAAPS 2026 PharmSci 360 Attendance
Cambrex
East Rutherford, NJ
CROs & CDMOs
CDMO for small-molecule drug substances, including continuous flow, controlled substances and peptides, plus analytical services.
Booth
Exhibiting at Booth 918
Mon, Oct 268:30am–5:00pmTue, Oct 278:30am–5:00pmWed, Oct 288:30am–1:30pm
Talk
Mon Oct 26
3:00pm–4:00pm
Phase Appropriate Nitrosamine Risk Management Strategies
360 Stage #1, Exhibit Hall
Manufacturing and Analytical Characterization

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Cambrex

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction